StockData
CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31

CITY THERAPEUTICS, INC.

$21.46−0.94 (-4.20%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

CITY THERAPEUTICS, INC. revenue by segment

No segment breakdown reported

City Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.